Inhibitor Therapeutics

INTI · OTC

$0.1099+$0.0119 (+12.14%)TodayMarket closed ·
Prev close $0.098

Latest news

  • Press releaseGlobe Newswire

    Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting

  • Press releaseGlobe Newswire

    Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.